from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0674/-

LFCtreatmentdescriptionclass of inhibitor

-0.817

Amikacinug/mL Amikacintranslation

-1.663

Cap5-10ug/mL Capreomycintranslation

-0.932

Rox10-50 ug/mL Roxithromycintranslation

-0.859

SM2-5 ug/mL Streptomycintranslation

-2.051

Tet5-10 ug/mL Tetracyclinetranslation

1.235

Rif0.2-5ug/mL Rifampicintranscription

-0.790

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.331

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.367

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.523

CPZ10-50 ug/mL Chlorpromazinerespiration

0.146

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.792

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.280

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.455

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.170

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.163

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.383

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.917

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.483

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.855

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.273

Nigericin50 uM Nigericinrespiration

0.340

TRC10-150 ug/mL Triclosanrespiration

-0.704

TRZ10-25 ug/mL Thioridazinerespiration

0.145

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.357

menadione6-10 ug/mL Menadionerespiration

0.478

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.358

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.120

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.400

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.338

NRP_1Non-replicating persistence stage 1dosRassociated

-1.034

Amp0.2mg/mL AmpicillincellWall

-0.354

Cephalexin20-100 ug/mL CephalexincellWall

-0.228

Cerulenin0.32-5 ug/mL CerulenincellWall

0.591

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.196

EMB10-20 ug/mL EthambutolcellWall

-1.288

Eta12-40 ug/mL EthionamidecellWall

-1.144

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.796

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.099

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.199

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.853

BZA0.12 mg/mL BenzamidearomaticAmides

0.646

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.110

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.398

H2O24 mM hydrogen peroxideDNAdamaging

0.541

Levo10 ug/mL LevofloxacinDNAdamaging

0.563

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.271

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.435

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.497

UVUV-irradiationDNAdamaging

-0.247

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.492

Antimycin12.5-50 ug/mL Antimycin A?

-0.683

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.904

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.461

PA8240.2-2 ug/mL PA-824?

-1.217

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.576

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.552

Verapamil50 uM Verapamil?

-0.594

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.213

methoxatin10-20 ug/mL Methoxatin?